Skip to main content
. Author manuscript; available in PMC: 2007 Nov 15.
Published in final edited form as: J Nucl Med. 2002 May;43(5):678–692.

TABLE 1.

Average Regional Tissue Radioactivity Measured 75–95 Minutes After Injection of (+)-11C-McN5652 or 11C-DASB

Radioligand* Pons MB Hypo Thalamus Put Cd FC PC TC CC OC Cereb
11C-McN5652
 Control 139 ± 9 144 ± 19 165 ± 21 144 ± 21 113 ± 7 105 ± 7 75 ± 12 85 ± 5 87 ± 10 83 ± 9 86 ± 9 84 ± 7
 MDMA 100 ± 3†‡ 115 ± 3 117 ± 10†  88 ± 12†  70 ± 2†‡  73 ± 7† 51 ± 5† 52 ± 3†‡ 63 ± 12† 56 ± 5† 50 ± 7† 53 ± 3†‡
 Paroxetine  94 ± 24†  99 ± 14†  98 ± 21† 106 ± 22 115 ± 28∥ 105 ± 22 84 ± 12∥ 92 ± 14∥ 92 ± 10∥ 85 ± 19 93 ± 16∥ 86 ± 17∥
11C-DASB
 Control 188 ± 24 194 ± 31 229 ± 33 185 ± 33 122 ± 16 136 ± 26 59 ± 3 56 ± 7 72 ± 9 72 ± 14 56 ± 5 55 ± 9
 MDMA 117 ± 17† 124 ± 16† 134 ± 29†  86 ± 16†  49 ± 10†‡  62 ± 7† 30 ± 2†‡ 29 ± 2†‡ 39 ± 9† 36 ± 2† 30 ± 3†‡ 30 ± 3†
 Paroxetine  56 ± 9†‡∥  54 ± 9†‡∥  54 ± 5†‡∥  56 ± 3†‡∥  55 ± 2†‡  51 ± 5†‡ 49 ± 5†∥ 53 ± 3∥ 57 ± 3†∥ 48 ± 3†∥ 50 ± 5∥ 44 ± 5∥
*

Each radioligand was tested 3 times in control baboon or different baboon lesioned previously with serotonergic neurotoxin MDMA.

†

Designates significant difference from control (ANOVA without correction for multiple comparisons).

‡

Designates significant difference from control (ANOVA with correction for multiple comparisons).

∥

Designates significant difference from MDMA (ANOVA without correction for multiple comparisons).

MB = midbrain; Hypo = hypothalamus; Put = putamen; Cd = caudate; FC = frontal cortex; PC = parietal cortex; TC = temporal cortex; CC = cingulate cortex; OC = occipital cortex; Cereb = cerebellum.

Values represent mean ± SD (n = 3).